Among these, B02 remains the most widely used RAD51 inhibitor, known to sensitize tumor cells to radiation and chemotherapy while sparing normal cells, and has been broadly applied in preclinical models to study HR repair inhibition [130]. The gene discussed is RAD51; the disease is neoplasm.